The results of the LEAD6 study are published in an article Online First and in a future edition of The Lancet. The findings are presented at the same time at the American Diabetes Association meeting in New Orleans, USA. They indicate that taking liraglutide once a day is more efficient in controlling blood glucose in [...]

A metaanalysis of five trials has shown that more intensive glucose control in type 2 diabetes leads to fewer heart attacks and heart disease events but has no significant effect on stroke or mortality from all causes. The findings are reported in an Article in this weeks diabetes special issue of The Lancet, written [...]